#France #Marseille #Avicenna.AI #CINA-VCF #CINA-CSpine

Avicenna.AI Secures CE Mark for Medical Imaging AI Tools

Avicenna.AI has made headlines by securing CE Mark certification for two of its advanced AI products designed for the diagnosis and management of spinal injuries. The tools, known as CINA-VCF Quantix and CINA-CSpine, have been recognized for adhering to rigorous European health and safety standards, allowing their deployment throughout the European Economic Area (EEA) without further regulatory delays.

The Rise of AI in Medical Imaging

As the healthcare industry rapidly evolves, artificial intelligence continues to reshape how practitioners approach diagnostics. Avicenna.AI, specializing in medical imaging AI, is at the forefront of this transformation. The significance of its CE Mark accreditation cannot be overstated, as it validates the company’s commitment to enhancing patient care through cutting-edge technology.

CINA-VCF Quantix: A Breakthrough in Identifying Vertebral Compression Fractures

CINA-VCF Quantix aims to detect unsuspected vertebral compression fractures (VCFs) in patients 50 years of age and older who are undergoing CT scans for unrelated medical issues. These fractures, often overlooked, can drastically impact a patient’s quality of life, contributing to chronic pain and diminished mobility. Current statistics reveal that approximately 750,000 adults in the U.S. face osteoporotic VCFs annually, with two-thirds remaining undiagnosed, leading to an increased risk for subsequent fractures.

This AI tool functions by automatically identifying and labeling spinal vertebrae, calculating the height loss ratios within the thoracic and lumbar spine. When a height loss ratio exceeds a critical threshold of 20%-25%, CINA-VCF Quantix notifies radiologists to prompt further examination. This proactive approach allows for timely intervention, a critical factor in avoiding more severe health complications and improving long-term patient outcomes.

CINA-CSpine: Enhancing Trauma Response for Cervical Spine Injuries

The other significant tool, CINA-CSpine, addresses the necessity for rapid diagnosis of cervical spine fractures. Caused primarily by trauma, these fractures can lead to neurological damage or paralysis if not addressed swiftly. The AI tool aids in automatically flagging potential acute fractures, enabling radiologists to act quickly, thus improving the chances of favorable outcomes for patients.

Importance of Timely Diagnosis

According to Cyril Di Grandi, co-founder and CEO of Avicenna.AI, “Osteoporotic vertebral fractures can have a profound impact on patients' quality of life. The launch of CINA-VCF Quantix in Europe represents a major step forward in preventive care, empowering clinicians to intervene before minor fractures escalate.” He emphasizes the effectiveness of CINA-CSpine in trauma care, noting that “by reducing the time between scan and diagnosis, we're helping radiologists catch cervical spine fractures faster and more reliably.” This emphasis on speed and efficiency underscores the AI’s role in enhancing the quality of care.

A Vision for Future Healthcare

Avicenna.AI's foundational vision involves integrating advanced AI technologies into everyday clinical workflows. The incorporation of both CINA-VCF and CINA-CSpine ensures that radiologists can seamlessly leverage these solutions within their existing systems, streamlining the diagnostics process and reducing the margin for error.

In addition to CINA-VCF and CINA-CSpine, Avicenna.AI offers various solutions targeted at critical areas such as intracranial hemorrhage detection, large vessel occlusion, aortic dissection, and more. As the company forges ahead, it is well-positioned to support healthcare professionals in tackling the challenges posed by severe pathologies detected through CT imaging.

Founded in 2018, Avicenna.AI comprises a diverse team of entrepreneurs and medical professionals committed to enhancing patient outcomes through innovative AI healthcare solutions. As the medical field embraces technological advancements, Avicenna.AI continues to lead the charge, advocating for a future where timely and accurate diagnosis is accessible to all.